BioSpace News Archive

Business

Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates

Minerva Neurosciences, Inc. today reported business updates and financial results for the second quarter ended June 30, 2023.

August 1, 2023
·
7 min read
Business

Harpoon Therapeutics Appoints Haibo Wang as Senior Vice President of Business Development

Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced the appointment of Haibo Wang as Senior Vice President of Business Development.

August 1, 2023
·
4 min read
Business

Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates

Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today reported financial results and business updates for the quarter ended June 30, 2023.

August 1, 2023
·
18 min read
Drug Development

Altimmune Announces Initiation of Phase 2b IMPACT Trial Evaluating the Efficacy and Safety of Pemvidutide in Non-Alcoholic Steatohepatitis (NASH)

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has enrolled the first subject in the Phase 2b IMPACT trial evaluating the efficacy and safety of pemvidutide in subjects with non-alcoholic steatohepatitis (NASH).

August 1, 2023
·
5 min read
Pharm Country

Trevi Therapeutics to Participate in Upcoming August Events

Trevi Therapeutics, Inc. today announced senior management will attend and participate in the following events in August.

August 1, 2023
·
2 min read
Business

Relmada Therapeutics to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on August 8, 2023

Relmada Therapeutics, Inc. today announced that it will report its financial results for the second quarter ended June 30, 2023 after the market close on Tuesday, August 8, 2023.

August 1, 2023
·
3 min read
Business

Syros to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Syros Pharmaceuticals today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, August 8, 2023 to report its second quarter 2023 financial results and provide a corporate update.

August 1, 2023
·
1 min read
Policy

Etiometry Gains FDA Clearance of AI-Based Algorithm that Alerts Risk of Hypercapnia for Neonates in Critical Care

Etiometry, the leader in clinical decision-support software, announced its IVCO2 Index™ was cleared by the Food and Drug Administration for use with neonatal ICU patients under 2kg, who are especially vulnerable to the effects of hypercapnia.

August 1, 2023
·
3 min read
Business

CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023

CytomX Therapeutics, Inc. today announced that it will report second quarter financial results on Tuesday, August 8, 2023, after the close of U.S. markets.

August 1, 2023
·
2 min read
Genetown

APNIMED to Participate in the 43rd Annual Canaccord Genuity Global Growth Conference

Apnimed, Inc. announced today the company will be participating in the upcoming 43rd Annual Canaccord Genuity Global Growth Conference at the InterContinental in Boston, Massachusetts on Wednesday, August 9, 2023.

August 1, 2023
·
3 min read